Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Kailesh Mistry
DB
Kailesh Mistry
Deutsche Bank
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-28.9%
Average Return
0 of 1 calls profitable · -44.3% vs benchmark
📈 Across the calls we could measure, roughly 0% of Kailesh Mistry's ratings turned a profit when each position was held for 1 year — averaging -28.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

10 Buy 14 Hold 0 Sell
Kailesh's Stock Coverage 20 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
CH:ZURN
Zurich Insurance Group
 Mar 26, 2026 HOLD Sell
+0.7% avg upside
14 analysts
$580.00
1.06% Upside
 ·
GB:PRU
Prudential
 Mar 19, 2026 BUY Strong Buy
+859.7% avg upside
22 analysts
$1440.00
42.54% Upside
 ·
IT:G
Assicurazioni Generali S.p.A.
 Mar 13, 2026 HOLD Buy
-15.3% avg upside
15 analysts
$37.50
11.39% Downside
 ·
GB:AV
Aviva plc
 Mar 09, 2026 BUY Buy
+3.4% avg upside
14 analysts
$765.00
20.61% Upside
 ·
DE:ALV
Allianz
 Feb 27, 2026 HOLD Buy
-10.3% avg upside
21 analysts
$400.00
0.10% Upside
 ·
FR:CS
AXA SA
 Feb 27, 2026 BUY Strong Buy
+4.5% avg upside
17 analysts
$45.50
7.36% Upside
 ·
GB:SDLF
Standard Life plc
 Jan 07, 2026 HOLD Buy
-2.1% avg upside
12 analysts
$755.00
6.65% Downside
 ·
GB:ADM
Admiral
 Jan 07, 2026 BUY Hold
-9.6% avg upside
9 analysts
$3550.00
5.67% Upside
 ·
GB:BEZ
Beazley
 Jan 07, 2026 BUY Strong Buy
+244.9% avg upside
9 analysts
$1050.00
18.23% Downside
 ·
GB:LGEN
Legal & General
 Jan 07, 2026 HOLD Buy
+554.4% avg upside
15 analysts
$270.00
5.25% Downside
 ·
NL:AGN
Aegon NV
 Jan 07, 2026 HOLD Buy
-8.4% avg upside
11 analysts
$7.30
1.29% Downside
 ·
HK:1299
AIA Group
 Jan 07, 2026 BUY Strong Buy
+41.6% avg upside
9 analysts
$98.00
32.95% Upside
 ·
GB:MNG
M&G Plc
 Jan 07, 2026 HOLD Buy
-9.6% avg upside
13 analysts
$290.00
11.50% Downside
 ·
HK:2328
PICC Property & Casualty Co
 Feb 27, 2025 HOLD Buy
+6.0% avg upside
7 analysts
$13.60
9.58% Downside
 ·
HK:1336
New China Life Insurance Co., Ltd. Class H
 Feb 27, 2025 HOLD Sell
-23.2% avg upside
5 analysts
$27.00
45.72% Downside
 ·
HK:1508
China Reinsurance (Group) Corp. Class H
 Feb 27, 2025 HOLD Hold
-25.6% avg upside
1 analyst
$0.90
25.57% Downside
 ·
HK:1339
People's Insurance Co (Group) of China
 Feb 27, 2025 HOLD Buy
+2.4% avg upside
6 analysts
$4.00
22.39% Downside
 ·
HK:2601
China Pacific Insurance (Group) Co
 Feb 27, 2025 HOLD Strong Buy
+25.2% avg upside
7 analysts
$26.00
8.70% Downside
 ·
HK:2318
Ping An Insurance Company of China
 Dec 13, 2024 BUY Strong Buy
+40.0% avg upside
10 analysts
$57.00
5.83% Upside
 ·
PUK
Prudential
 Mar 23, 2021 BUY Strong Buy
+0.6% avg upside
6 analysts
 — -28.9%
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Kailesh Mistry — Frequently Asked Questions
How accurate are Kailesh Mistry's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Kailesh's ratings were profitable over a one-year hold, with an average return of -28.9% per rating, or -44.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Kailesh ranked on 13Foresight?
Kailesh Mistry is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Kailesh cover?
Kailesh most recently has ratings on CH:ZURN, GB:PRU, IT:G, GB:AV, DE:ALV, FR:CS, GB:SDLF, GB:ADM, GB:BEZ, GB:LGEN, NL:AGN, HK:1299 and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.